Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Titan Pharmaceuticals (TTNP) to Explore Strategic Alternatives

  • August 18, 2022

Titan Pharmaceuticals (TTNP) announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value.


August 16, 2022: Lazar was appointed interim Chairman and Chief Executive Officer, with a mandate to lead Titan’s continuing review of strategic alternatives.